Roche in Malaysia signs MoU with Premier Integrated Labs
Roche (Malaysia) Sdn Bhd, in collaboration with Roche Diagnostics and Premier Integrated Labs (PILs), has signed an MoU to enhance awareness and accessibility of Comprehensive Genomic Profiling (CGP) for cancer patients in Malaysia. CGP enables personalized cancer treatment by analyzing a wide panel of genes associated with cancer growth.
The partnership aims to transcend socio-economic and geographic barriers, making CGP accessible to all patients. This collaborative effort signifies a commitment to advancing healthcare in Malaysia, emphasizing personalized medicine and the transformative potential of genetics in healthcare.
Heng Chai Yin, General Manager of Roche Diagnostics (M) Sdn. Bhd. says, “At Roche, we have a passion for innovation and we strive to improve patient access in Malaysia as healthcare that is built on people’s needs, strong data and clinical insights is healthcare that saves lives.”
Oracle is laying off thousands of employees globally to restructure and invest in AI, while…
Wall Street rallies as Iran signals willingness to end war; Dow jumps 1,125 points, oil…
Digital banks move into execution phase as competition intensifies.
SMEs face cost pressures while adapting to growing competition.
Najib Razak ordered to pay SRC International US$1.3 billion for breach of fiduciary duties, misappropriation,…
Backup alone doesn't ensure recovery; organizations must establish clear recovery strategies, targets, and practices for…
This website uses cookies.